20233 ⎘
Medicinal preparations containing organic active ingredients; Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
Sub-classes:METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING STRESS-RELATED DISORDER
#2ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
#3Substituted Bicyclic Compounds, Compositions and Methods of Use
#4STAPHYLOCOCCUS AUREUS PBP4 INHIBITORS AND METHOD OF USE
#5COMPOSITIONS AND METHODS FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION
#6FORMULATION AND A METHOD OF TREATING CARCINOMA
#7Inhibition of Natural Killer Cell Cytoxocity
#8COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
#9APPLICATION OF CARBASALATE CALCIUM IN PREPARING DRUG FOR TREATMENT OF HYDROCEPHALUS
#10Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters
#11DOUBLE TARGETED CONSTRUCTS TO AFFECT TUMOR KILL
#12TREATING CANCERS WITH COMBINATIONS OF ANTI-CD20 ANTIBODY AND ACYLFULVENES
#13COMPOSITIONS AND METHODS OF TREATMENT FOR TINEA PEDIS
#14RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION
#15NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A AGONISTS AND METHODS OF USE FOR TREATMENT OF INFECTIOUS DISEASES
#16ROOM STABLE HYDROXYUREA ORAL SUSPENSION
#17Neurotrophic Receptor Tyrosine Kinase (NTRK) Inhibitors and Methods Using Same
#18SYNERGISTIC INTERACTIONS FOR IMPROVED CANCER TREATMENT
#19PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYUREA FOR USE IN THE TREATMENT OF SEVERE CHRONIC ANEMIA
#20Topical Roflumilast Aerosol Foams
#21COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT
#22SMALL MOLECULE BROAD-SPECTRUM ANTIBIOTICS
#23METHODS AND COMPOSITIONS FOR TREATMENT OF SKIN
#24Compositions and Methods for Treating Cancer
#25METHODS FOR DETECTING ACUTE MYELOID LEUKEMIA
#26KIT FOR PREPARING INJECTABLE CARMUSTINE SOLUTIONS
#27A SKIN CARE COMPOSITION
#28USE OF RIFAXIMIN ON CIRCULATING AGED NEUTROPHILS IN SICKLE CELL DISEASE
#29COMPOSITION COMPRISING THIOUREA DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROTIC DISEASE
#30USE OF THBS1 INHIBITOR FOR OVERCOMING DRUG RESISTANCE IN CANCER
#31STABLE AQUEOUS HYDROXYCARBAMIDE SOLUTION
#32COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDER
#33COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#34METHODS OF TREATING A SUBJECT HAVING CLINICALLY SIGNIFICANT SIGNS AND SYMPTOMS ASSOCIATED WITH BLOOD CELL DIFFERENTIATION
#351,4-DIUREAS AND 1,4-DITHIOUREAS AND USES THEREOF
#36PHARMACEUTICAL COMBINATION FOR PREVENTING OR TREATING EPILEPTIC SEIZURE AND THE USE THEREOF
#37COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES
#38METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
#39ERCC1-XPF COMPLEX INHIBITOR COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER
#40AMINO-ARYL-BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOF
#41COMPOSITIONS AND METHODS OF TREATMENT OF DISEASE USING COMBINATION OF A NITRODILATOR AND A NITROGEN OXIDE COMPOUND
#42SPLEEN TYROSINE KINASE INHIBITOR, COMPOSITION, AND METHODS OF USE
#43TREATMENT FOR HOT FLUSHES
#44STABLE PHARMACEUTICAL COMPOSITIONS OF HYDROXYUREA
#45MEDICINE COMPRISING COMBINATION OF ANTI-MUTANT-CALR ANTIBODY AND ANOTHER DRUG
#46METHOD FOR TREATING BREAST CANCERS AND PARP RESISTANT BREAST CANCERS
#47NOVEL COMPOSITIONS FOR THE MANAGEMENT OF HYPONATREMIA SUITABLE FOR PACKAGING IN MULTI-USE CONTAINER
#48A MIXTURE OF UREA, BIURET AND N-CONTAINING BY-PRODUCTS CREATED DURING BIURET PRODUCTION AS A DIETARY NON-PROTEIN NITROGEN-SOURCE FOR RUMINANTS AND USES THEREOF
#49COMBINATION TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN PATIENTS WITH RAS PATHWAY MUTATIONS
#50CLAUDIN INHIBITORS AND METHODS OF USE THEREOF
#514-SUBSTITUTED-PHENYL ACETAMIDES AND ARYLUREAS AS AGONISTS FOR THE ORPHAN RECEPTOR GPR88
#52A MIXTURE OF UREA, BIURET AND NITRATE AS A DIETARY NON-PROTEIN NITROGEN-SOURCE FOR RUMINANTS AND USES THEREOF
#53Nutritional Compositions For The Management of Hyponatremia
#54ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS AND USE THEREOF
#55METHODS FOR EVALUATION AND TREATMENT OF TYROSINE KINASE INHIBITOR (TKI)-RESISTANT ACUTE MYELOID LEUKEMIA
#56METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION
#57COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#58COMPOSITIONS AND METHODS RELATING TO PEDIATRIC NEUROMUSCULAR DISEASES AND NEUROGENERATIVE DISORDERS
#59SULFONATED AND PHOSPHORYLATED AROMATIC MOLECULES
#60TREATING CANCERS WITH COMBINATIONS OF ACYLFULVENES WITH IBRUTINIB AND/OR BORTEZOMIB
#61PHARMACEUTICAL COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF SARCOPENIA, CONTAINING ROR-alpha ACTIVATOR JC1-40
#62SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
#63MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#64Chemical Activators of Nicotinamide Mononucleotide adenylyltransferase 2 (NMNAT2) and Uses Thereof
#65ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE
#66USE OF HYPERPOLARIZING AGENTS ALONE AND IN COMBINATION WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCERS INCLUDING GLIOBLASTOMA
#67METHODS OF ADMINISTERING A MODULATOR OF HEMOGLOBIN
#68COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS
#69TOPICAL COMPOSITION FOR ADMINISTRATION TO NAILS
#70METHODS OF TREATING OR PREVENTING A COMPLICATION OF SICKLE CELL DISEASE
#71COMPOUNDS AND METHOD OF USE THEREOF FOR TREATING BACTERIAL DISEASES
#72CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
#73COMPOSITIONS AND METHODS FOR IMPROVING NITROGEN UTILIZATION IN A RUMINANT
#74COMPOSITIONS AND METHODS FOR TREATMENT OF MIC60 DEPLETED CANCERS AND METASTASIS
#75BICYCLOPENTANE DERIVATIVES
#76COMPOSITIONS IN THE FORM OF A UREA POWDER
#77RXFP1 AGONISTS
#78Treating Cancers with Combinations of Spironolactone and Acylfulvenes
#79COMPOSITION COMPRISING GLYCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR
#80Methods of Treating Conditions Associated with Leaky Gut Barrier
#81METHODS OF ENHANCING MILK PRODUCTION IN LACTATING MAMMALIAN SUBJECTS
#82METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT
#83COMPOSITIONS AND METHODS FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION
#84COMPOSITIONS AND METHODS FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION
#85G-ALPHA-S INHIBITORS AND USES THEREOF
#86MOLECULAR GLUE AND SALL4 DEGRADER
#87FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS
#88TREATMENT OF BRAIN METASTASES AND CNS METASTASES USING ILLUDINS OR HYDROXYLUREAMETHYL ACYLFULVENE
#89METHOD FOR QUANTIFYING AHSP PROTEIN AND ITS USE FOR PROGNOSING A HAEMOGLOBIN-RELATED DISORDER
#90The Use of Thiourea and Thiourea Derivatives As Potentiators of Antibacterial Activity of Peptoids
#91Methods and Compositions for Treating Cancer
#926-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES
#93SUCCINIC ACID AND DERIVATIVES FOR THE TREATMENT OF HAEMOTOLOGICAL DISORDERS
#94TREATING CANCERS WITH COMBINATIONS OF PARP INHIBITOR AND ACYLFULVENES
#95TABLET FOR ORAL SUSPENSION
#96AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#97PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR FOR TREATMENT OR TREATMENT OF RNA VIRAL INFECTIONS
#98NLRP3 ACTIVATORS FOR USE IN THE TREATMENT OF INFECTIOUS DISEASES OR CANCER BY ACTIVATING NLRP3 INFLAMMASOME
#99ANTIMICROBIAL COMPOSITION
#100METHODS FOR TREATING NERVOUS SYSTEM DISORDERS WITH ANTIPURINERGIC AGENTS
#101ANTIBIOTIC-FREE ANTIMICROBIAL FEED ADDITIVES AND ANTIMICROBIAL COMPOSITIONS
#102HDAC6 INHIBITORS FOR TREATMENT OF DILATED CARDIOMYOPATHY
#103METHODS OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE INCLUDING COMPOUNDS USEFUL THEREIN
#104HDAC6 INHIBITORS FOR TREATMENT OF METABOLIC DISEASE AND HFPEF
#105PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ONYCHOMYCOSIS AND PREPARATION METHOD THEREFOR
#106DEOXY-CYTIDINE OR URIDINE DERIVATIVES FOR USE IN CANCER THERAPIES
#107COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE
#108Combination Therapy for Metastatic Cancer
#109COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDER
#110ENHANCED ERYTHROPOIESIS AND IRON METABOLISM
#111COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#112METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS
#113ANTI-MYCOBACTERIAL DRUGS
#114TREATMENT OF INFECTIONS AND BIOFILM FORMATION USING A CELLULOSE SYNTHASE INHIBITOR
#115COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF COMPOUNDS THAT PROTECT AGAINST LIPOFUSCIN CYTOTOXICITY
#116Method for Treating Blood Cancers
#117MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF
#118COMBINATION THERAPIES FOR TREATING CANCER
#119THERAPEUTIC COMBINATIONS INCLUDING INHIBITORS OF THE P2X4 RECEPTOR FOR TREATING AND PREVENTING PROLIFERATIVE DISORDERS
#120COMPOSITIONS AND METHODS FOR AMELIORATING HELICOBACTERACEAE INFECTIONS
#121METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASE
#122Anti-mycobacterial drugs
#123Methods of intravenous administration of glyburide
#124RIFAXIMIN LIQUID FORMULATIONS FOR USE INTHE TREATMENT OF SICKLE CELL DISEASE
#125TABLET FOR ORAL SUSPENSION
#126COMPOSITIONS FOR AND METHODS OF TREATING CANCER
#127INTRANASAL ADMINISTRATION OF SURAMIN FOR TREATING NERVOUS SYSTEM DISORDERS
#128HDAC6 inhibitors for treatment of metabolic disease and HFpEF
#129Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
#130Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
#131AMPK Activators and Methods of Use Thereof
#132Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
#133METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO
#134ANTIMICROBIAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
#135Wound-care composition and method of use
#136Method for treating rhabdoid tumors
#137COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase
#138STABLE PHARMACEUTICAL COMPOSITIONS OF HYDROXYUREA
#139METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS
#140Dosing parameters for CD47 targeting therapies to hematologic malignancies
#141BRIGHTENING COSMETIC COMPOSITION COMPRISING SODIUM PYRUVATE AS ACTIVE INGREDIENT
#142Sodium nitrite-containing pharmaceutical compositions
#143SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS
#144DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
#145THERAPEUTIC DRUG FOR POLYCYTHEMIA
#146COMBINATION THERAPIES FOR TREATING CANCER
#147Compositions and methods for the treatment of meibomian gland dysfunction
#148MONO- AND COMBINATION THERAPIES
#149Substituted Alkynylene Compounds As Anticancer Agents
#150METHOD FOR RAPID INFUSION OF CARMUSTINE
#151Topical Roflumilast Aerosol Foams
#152Hydroxyureamethyl-Acylfulvene for Treating Brain Cancer or CNS Cancer
#153Method For Treating Pancreatic Cancer
#154CONDENSATION PRODUCT FOR USE IN A METHOD FOR THE TREATMENT OF COVID-19
#155METHODS AND COMPOSITIONS FOR INDUCING FETAL HEMOGLOBIN
#156METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT
#157METHODS OF USING SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF SICKLE CELL DISEASE
#158COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#159Treatment for hot flushes
#160Compositions and Methods for Identifying and Treating Dystonia Disorders
#161Compounds and uses thereof
#162PHARMACEUTICAL COMPOSITION FOR INHIBITING INFLAMMATORY RESPONSE COMPRISING HYDROXYUREA
#163COMPOUNDS AND USES THEREOF
#164Targeting Mcl-1 to Enhance DNA Replication Stress Sensitivity for Cancer Therapy
#165ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE
#166STABILIZING VITAMIN C TOPICAL FORMULATIONS
#167COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN ASSOCIATED WITH MALIGNANT GROWTH DISORDER
#168COMBINATION CANCER THERAPY USING CHK INHIBITOR
#169Methods and compositions of inhibiting DCN1-UBC12 interaction
#170CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
#171METHODS OF TREATING CANCER
#172COMPOSITION FOR DETERMINATION OF CELL-MEDIATED IMMUNE RESPONSIVENESS
#173Preventing, treating, and curing illness by denaturing proteins and nucleic acids
#174METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE
#175PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING ANTICANCER VIRUS, IMMUNE CHECKPOINT INHIBITOR AND HYDROXYUREA AS ACTIVE INGREDIENTS
#176PSYCHEDELICS FOR TREATMENT OF PAIN
#177Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
#178METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE AND THALASSEMIA
#179CANCER TREATMENT
#180Substituted bicyclic compounds
#181COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#182METHODS AND COMPOSITIONS FOR INHIBITING GAPDH
#183Compositions and Methods for Identifying and Treating Dystonia Disorders
#184PHARMACEUTICAL COMPOSITION COMPRISING VACCINIA VIRUS AND HYDROXYUREA AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER
#185BIOPHOTONIC COMPOSITIONS FOR TREATING SKIN AND SOFT TISSUE WOUNDS HAVING EITHER OR BOTH NON-RESISTANT AND RESISTANT INFECTIONS
#186BROMODOMAIN INHIBITORS TO TARGET THERAPY-RESISTANT CANCER
#187METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED BY BIOLOGICAL TARGETED CANCER DRUGS
#188Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
#189Methods And Compositions For Enhancing AAV-Mediated Homologous Recombination Using Ribonucleotide Reductase Inhibitors
#190COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG INFLAMMATION
#191EZH2 INHIBITION IN COMBINATION THERAPIES FOR THE TREATMENT OF CANCERS
#192pH STABLE UREA COMPOSITION AND USE THEREOF
#193ASPARAGINASE-BASED CANCER THERAPY
#194COMPOSITIONS FOR TREATMENT OF SUBSTANCE USE DISORDER
#195PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYUREA FOR USE IN THE TREATMENT OF SEVERE CHRONIC ANEMIA
#196Nutritional compositions for the management of hyponatremia
#197COMPOSITIONS AND METHODS FOR TREATING NAIL INFECTIONS
#198Methods and Compositions for Treating Cancer
#199AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#200HISTONE DEACETYLASE AS A MODULATOR OF PDLI EXPRESSION AND ACTIVITY
#201USE OF RIFAXIMIN ON CIRCULATING AGED NEUTROPHILS IN SICKLE CELL DISEASE
#202COMBINATION THERAPY
#203Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto
#204COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
#205COMPOSITION INCLUDING GLUCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR
#206Deoxy-cytidine or uridine derivatives for use in cancer therapies
#207ENHANCED BIOAVAILABILITY OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)-PHENYL)CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE
#208PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ACIDOSIS
#209Combination Therapy for Metastatic Cancer
#210SUBCONJUNCTIVAL CHEMOTHERAPEUTIC DELIVERY BY FIBRIN SEALANT IN THE TREATMENT OF RETINOBLASTOMA
#211COMPOSITION FOR PROMOTING THE SKIN MICROBIOME
#212METHOD FOR PREVENTING OR TREATING PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
#213METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT
#214Compositions and methods of treatment for tinea pedis
#215Transition Metal Macrocyclics as MRI Contrast Agents for Molecular Imaging
#216Compound for treating cancer and diabetes
#217METHODS FOR DETECTING ACUTE MYELOID LEUKEMIA
#218Compositions including a therapeutic antibodies and/or a checkpoint inhibitor and an integrin activating compound
#219HISTONE DEACETYLASE 6 INHIBITION FOR ENHANCING T-CELL FUNCTION DURING ANTI-TUMOR RESPONSE AND TUMOR-PEPTIDE VACCINATION
#220MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#221Dosing parameters for CD47 targeting therapies to hematologic malignancies
#222[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
#223Substituted alkynylene compounds as anticancer agents
#224METHODS AND TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN MICROVASCULAR DYSFUNCTION
#225hTERT MODULATORS AND METHODS OF USE
#226METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE
#227SMALL MOLECULE ACTIVATORS OF POLYCYSTIN-2 (PKD2) AND USES THEREOF
#228NANOPARTICLE FORMULATIONS AND METHODS OF USE FOR ALPHA CONNEXIN C-TERMINAL PEPTIDES
#229CARMUSTINE FORMULATION
#230Delivery of Urea to Cells of the Macula and Retina Using Liposome Constructs
#231Amino-aryl-benzamide compounds and methods of use thereof
#232COMPOSITIONS FOR ADMINISTRATION TO ANIMALS TO INCREASE GUT NON-PROTEIN NITROGEN LEVELS
#233SHIELDING AGENTS AND THEIR USE
#234COMPOSITIONS AND METHODS FOR TREATING CANCER
#235Treatment of infections and biofilm formation using a cellulose synthase inhibitor
#236METHODS OF DETERMINING TREATMENT CONSISTING OF RADIATION THERAPY AND/OR ALKYLATING CHEMOTHERAPY IN PATIENTS SUFFERING FROM CANCER
#237LIQUID EMBOLICS
#238Methods and compositions for reversing or mitigating skin aging
#239Methods of use of cyclopamine analogs
#240SUCCINIC ACID AND DERIVATIVES FOR THE TREATMENT OF HAEMOTOLOGICAL DISORDERS
#241GLYCOALKALOID COMBINATIONS AND VARIOUS USES THEREOF
#242METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS
#243MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF
#244METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS
#245Combination of cannabis, derivatives thereof and additives in oral care compositions
#246Compositions and methods for the treatment of meibomian gland dysfunction
#247Methods for the Treatment of Solid Tumor Cancers Using Illudins and Biomarkers
#248ANTIBIOTIC-FREE ANTIMICROBIAL FEED ADDITIVES AND ANTIMICROBIAL COMPOSITIONS
#249A STABLE AQUEOUS HYDROXYCARBAMIDE SOLUTION
#250Methods and compositions to modulate the gut microbiota and to manage weight
#251COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE
#252Methods and compositions to modulate the gut microbiota and to manage weight
#253METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT
#254COMBINATION THERAPIES FOR TREATING CANCER
#255Methods of intravenous administration of glyburide
#256Compositions and Methods for Treating Sickle Cell Disease
#257Double targeted constructs to affect tumor kill
#258USE OF CELIPROLOL FOR TREATING VASCULAR EHLERS-DANLOS SYNDROME IN WOMEN DURING PREGNANCY AND PERIPARTUM PERIOD
#259Method for the formulation of oil-soluble substances, and powders obtainable thereof
#260Antibacterial compounds
#261Methods of Treating Conditions Associated with Leaky Gut Barrier
#262Antimicrobial composition
#263Enhanced erythropoiesis and iron metabolism
#264Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters
#265Enhanced erythropoiesis and iron metabolism
#266SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR TREATING CANCER
#267Managing Cardiovascular Conditions Associated with Kidney Disease
#268Sodium nitrite-containing pharmaceutical compositions
#269Nutritional compositions for the management of hyponatremia
#270ANTITUMOR NANO-DRUG
#271Carbamoyl phenylalaninol analogs and uses thereof
#272PDE9 INHIBITORS FOR TREATMENT OF PERIPHERAL DISEASES
#273CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS
#274Compositions and methods for identifying and treating dystonia disorders
#275Methods and compositions of inhibiting DCN1-UBC12 interaction
#276Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents
#277Enhanced moisturizing lotion compositions
#278Mu opioid receptor modulators
#279N-ACETYLCYSTEINE AND UREA-BASED FORMULATION FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
#280Mitofusin activators and methods of use thereof
#281Fatty acid synthase inhibitor and application thereof
#282KIT FOR PREPARING INJECTABLE CARMUSTINE SOLUTIONS
#283Integrin activator vaccine compositions
#284Methods for treating protozoan infections
#285USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES
#286USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES
#287Method of providing celiprolol therapy to a patient
#288PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING ANTICANCER VIRUS AND HYDROXYUREA AS EFFECTIVE COMPONENTS
#289PHARMACEUTICAL FORMULATION FOR CARGLUMIC ACID
#290USING COLIPASE INHIBITORS TO TREAT PANCREATITIS
#291Targeting Lipid Metabolism and Free Fatty Acid (FFA) Oxidation to Treat Diseases Mediated by Resident Memory T Cells (TRM)
#292hTERT MODULATORS AND METHODS OF USE
#293Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
#294Methods and Compositions for Treating Cancer
#295Mitofusin activators and methods of use thereof
#296Methods and compositions for treatment of pigmented lesions
#297Compositions and methods for the treatment of meibomian gland dysfunction
#298DRUG COATED BALLOON
#299Targeting Mcl-1 to enhance DNA replication stress sensitivity for cancer therapy
#300Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting